Old Web
English
Sign In
Acemap
>
authorDetail
>
Lauri Welles
Lauri Welles
Élan
Prednisone
Non-Hodgkin's lymphoma
Hodgkin's lymphoma
Medicine
Oncology
3
Papers
95
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I/II Trial of Nonpegylated Liposomal Doxorubicin, Cyclophosphamide, Vincristine, and Prednisone in the Treatment of Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
2006
Clinical Lymphoma, Myeloma & Leukemia
Anil Tulpule
Byron M. Espina
N. Berman
Laura H. Buchanan
D. Lynne Smith
Andy Sherrod
Dharshika Dharmapala
Conway Gee
William D. Boswell
Bharat N. Nathwani
Lauri Welles
Alexandra M. Levine
Show All
Source
Cite
Save
Citations (24)
Liposome-Encapsulated Doxorubicin in Combination With Standard Agents (cyclophosphamide, vincristine, prednisone) in Patients With Newly Diagnosed AIDS-Related Non-Hodgkin's Lymphoma: Results of Therapy and Correlates of Response
2004
Journal of Clinical Oncology
Alexandra M. Levine
Anil Tulpule
Byron M. Espina
Andy Sherrod
William D. Boswell
Robert D. Lieberman
Bharat N. Nathwani
Lauri Welles
Show All
Source
Cite
Save
Citations (69)
A phase I/II trial of liposomal doxorubicin (tlc-d99, myocet) in combination with cyclophosphamide, vincristine, and prednisone (comp) for newly diagnosed intermediate and high grade non-Hodgkin's lymphoma (nhl)
2001
European Journal of Cancer
Anil Tulpule
Byron M. Espina
N. Berman
Laura H. Buchanan
William D. Boswell
Lauri Welles
Alexandra M. Levine
Show All
Source
Cite
Save
Citations (2)
1